Eledon Pharmaceuticals, Inc. (ELDN)
2.99
-0.02
(-0.66%)
USD |
NASDAQ |
Sep 02, 16:00
2.985
0.00 (0.00%)
After-Hours: 20:00
Eledon Pharmaceuticals Net Income (TTM) : -98.56M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -98.56M |
| March 31, 2026 | -78.15M |
| December 31, 2025 | -45.62M |
| September 30, 2025 | -79.79M |
| June 30, 2025 | -7.899M |
| March 31, 2025 | -41.59M |
| December 31, 2024 | -58.73M |
| September 30, 2024 | -99.95M |
| June 30, 2024 | -164.28M |
| March 31, 2024 | -185.13M |
| December 31, 2023 | -172.28M |
| September 30, 2023 | -144.82M |
| June 30, 2023 | -145.39M |
| March 31, 2023 | -88.87M |
| December 31, 2022 | -87.97M |
| September 30, 2022 | -38.39M |
| June 30, 2022 | -37.73M |
| March 31, 2022 | -35.87M |
| December 31, 2021 | -34.51M |
| September 30, 2021 | -31.60M |
| June 30, 2021 | -27.93M |
| March 31, 2021 | -23.13M |
| December 31, 2020 | -22.81M |
| September 30, 2020 | -21.05M |
| June 30, 2020 | -17.80M |
| Date | Value |
|---|---|
| March 31, 2020 | -19.31M |
| December 31, 2019 | -16.01M |
| September 30, 2019 | -16.44M |
| June 30, 2019 | -17.04M |
| March 31, 2019 | -16.14M |
| December 31, 2018 | -14.06M |
| September 30, 2018 | -11.60M |
| June 30, 2018 | -11.08M |
| March 31, 2018 | -13.37M |
| December 31, 2017 | -10.81M |
| September 30, 2017 | -8.92M |
| June 30, 2017 | -6.304M |
| March 31, 2017 | -0.998M |
| December 31, 2016 | -12.18M |
| September 30, 2016 | -22.97M |
| June 30, 2016 | -34.47M |
| March 31, 2016 | -43.25M |
| December 31, 2015 | -45.09M |
| September 30, 2015 | -40.28M |
| June 30, 2015 | -34.82M |
| March 31, 2015 | -31.71M |
| December 31, 2014 | -23.30M |
| September 30, 2014 | -21.61M |
| June 30, 2014 | -17.61M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.405B |
| Viking Therapeutics, Inc. | -534.80M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |